Legal Representation
Attorney
                                            Rachelle A. Dubow, Esq.
                                        USPTO Deadlines
                                Next Deadline
                            
                            
                                    
                                        
                                        18 days remaining
                                    
                            
                        Non-Final Action Mailed
                                    
                                    Due Date
                                
                                
                                    November 18, 2025
                                
                            
                                        
                                        Extension Available
                                    
                                    
                                        Until February 18, 2026
                                    
                                
                            
                            Additional deadlines exist. Contact your attorney for complete deadline information.
                        
                Application History
21 events| Date | Code | Type | Description | Documents | 
|---|---|---|---|---|
| Aug 18, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... | 
| Aug 18, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... | 
| Aug 18, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... | 
| May 27, 2025 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... | 
| Nov 26, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... | 
| Nov 26, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... | 
| Nov 26, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... | 
| Nov 25, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... | 
| Nov 25, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... | 
| Nov 25, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... | 
| Sep 5, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... | 
| Sep 5, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... | 
| Jun 26, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... | 
| Jun 26, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... | 
| Jun 26, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... | 
| Jun 7, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... | 
| Jun 7, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... | 
| Jun 7, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... | 
| Jun 6, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... | 
| Nov 1, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... | 
| Oct 30, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... | 
Detailed Classifications
                                                Class 001
                                            
                                        Chemical reagents and RNA sequences being chemical reagents for agricultural purposes, and not medical or veterinary purposes, namely, for crop protection and to improve plant health and plant yield; chemical treatments applied to seeds, plants and crops to improve plant health and yield
                                        
                                                Class 005
                                            
                                        Chemical reagents and RNA sequences being chemical reagents used to repel or destroy insects, pests, parasites, and vermin; Agricultural products, namely, insecticides, pesticides, fungicides; preparations for destroying vermin; Chemical reagents and RNA sequences being chemical reagents used for improving bee health; Pharmaceutical products and veterinary products for human and animal health in the nature of vaccines and RNA therapeutics for the treatment of parasitic infection or infestations, infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, and cancer; Antibiotics; Vaccines; Gene therapy products, namely, mRNA therapeutics and siRNA therapeutics for medical or clinical use for the treatment of infectious diseases, respiratory diseases, immune system diseases, cardiovascular diseases, and cancer; RNA in the nature of vaccines and therapeutics for scientific, research, medical, pharmaceutical, veterinary, agricultural, industrial and manufacturing use for the treatment of infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, parasitic infection or infestation, and cancer
                                        
                                                Class 040
                                            
                                        Cell-Free processing and manufacturing of RNA for others; biological manufacturing and cell-free processing of RNA for others
                                        
                                                Class 042
                                            
                                        Research and development services in the field of RNA for scientific, engineering, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use; research and development services in the field of synthetic and recombinant biology and formulations; design and engineering in the field of producing RNA and cell-free processing; research and development services in the field of producing, manufacturing, and processing of RNA and RNA formulations for scientific, research, medical, pharmaceutical, veterinary, agricultural food, chemical and energy production, industrial and manufacturing use; research and development services in the field of formulations for the delivery of RNA for scientific, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use
                                        Additional Information
                                                
                                                Design Mark
                                            
                                        The mark consists of GREENLIGHT BIOSCIENCES in stylized format.
                                    
                                                
                                                Color Claim
                                            
                                        Color is not claimed as a feature of the mark.
                                    
                                                
                                                Pseudo Mark
                                            
                                        GREEN LIGHT BIOSCIENCES
                                    Classification
                                            
                                            International Classes
                                        
                                        
                                                    001
                                                    005
                                                    040
                                                    042